Search Results
Test Catalog
FWFHG - Overview: Venom W-F Hornet IgG
Venom W-F Hornet IgG
FBROM - Overview: Bromine - Total, Blood
Bromine - Total, Blood
FACN1 - Overview: Anti-cN-1A (NT5c1A) IBM
Anti-cN-1A (NT5c1A) IBM
2AINH - Overview: Factor II Inhibitor Profile, Professional Interpretation
Interpretation of testing for the detection and quantitation of inhibitor to factor II
7AINH - Overview: Factor VII Inhibitor Profile, Professional Interpretation
Interpretation of testing for the detection and quantitation of inhibitor to factor VII
10AIH - Overview: Factor X Inhibitor Profile, Professional Interpretation
Interpretation of the detection and quantitation of inhibitor to coagulation factor X
11AIH - Overview: Factor XI Inhibitor Profile, Professional Interpretation
Interpretation of testing for the detection and quantitation of inhibitor to coagulation factor XI
9AINH - Overview: Factor IX Inhibitor Profile, Professional Interpretation
Interpretation for the detection and titering of coagulation inhibitor to the specific factor requested, primarily factor IX in patients with hemophilia B
CU Index
FHI24 - Overview: Histamine, 24-Hour Urine
Histamine, 24-Hour Urine
FGAGA - Overview: Golimumab and Anti-Golimumab Antibody, DoseASSURE GOL
Golimumab and Anti-Golimumab Antibody, DoseASSURE GOL
FNMEN - Overview: Neisseria Meningitidis IgG Vaccine Response
Neisseria Meningitidis IgG Vaccine Response
SMPB - Overview: Peripheral Blood Smear Review
Confirmation of red blood cell membrane morphology
FPROS - Overview: Prostaglandin D2 (PG D2), Random Urine
Prostaglandin D2 (PG D2), Random Urine
FPHET - Overview: Anti-Phosphatidylethanolamine Panel
Anti-Phosphatidylethanolamine Panel
FBSQU - Overview: Bath Salts Panel (Qualitative), Urine
Bath Salts Panel (Qualitative), Urine
10INT - Overview: Factor X Inhibitor Profile, Technical Interpretation
Technical interpretation of inhibitor to coagulation factor X testing
5AINH - Overview: Factor V Inhibitor Profile, Professional Interpretation
Interpretation of testing for factor V inhibitors
Interpretation of testing performed as part of a profile to evaluate laboratory evidence of disseminated intravascular coagulation
5INHT - Overview: Factor V Inhibitor Profile, Technical Interpretation
Technical interpretation of inhibitor to factor V testing
FKEMS - Overview: Ketamine and Metabolite Screen, Plasma
Ketamine and Metabolite Screen, Plasma
11INT - Overview: Factor XI Inhibitor Profile, Technical Interpretation
Technical interpretation of inhibitor to coagulation factor XI testing This test is not useful for the detection of a lupus-like circulating anticoagulant inhibitor, a nonspecific circulating anticoagulant, or other inhibitors that are...
9INHT - Overview: Factor IX Inhibitor Profile Technical Interpretation
Technical interpretation of inhibitor to factor IX testing for patients with hemophilia B
2INHT - Overview: Factor II Inhibitor Profile, Technical Interpretation
Technical interpretation of inhibitor to factor II testing This test is not useful for the detection of a lupus-like circulating anticoagulant inhibitor, a nonspecific circulating anticoagulant, or other inhibitors that are not specific...
7INHT - Overview: Factor VII Inhibitor Profile, Technical Interpretation
Technical interpretation of inhibitor to coagulation factor VII testing
CH8BI - Overview: Chromogenic Factor VIII Inhibitor Bethesda Profile Interpretation
Interpretation of CHF8P / Chromogenic Factor VIII Inhibitor Bethesda Profile, Plasma Detecting the presence and titer of a specific factor inhibitor directed against coagulation factor VIII This test is not useful for detecting the...
Increased levels of neopterin are found during impaired renal function and viral infection in transplant patients. Elevated levels are also indicators for conditions related to impaired cellular immunity.
EEEVI - Overview: Red Blood Cell (RBC) Enzyme Interpretation
Interpretation of results for the red blood cell enzyme evaluation Identifying defects of red cell enzyme metabolism Evaluating patients with Coombs-negative hemolytic anemia
ADALX - Overview: Adalimumab Quantitative with Reflex to Antibody, Serum
Therapeutic drug monitoring of adalimumab concentration and antibody levels, if appropriate
CHIKI - Overview: Chikungunya Interpretation
Interpretation of testing that aids in the diagnosis of recent infection with Chikungunya virus in patients with recent travel to endemic areas and a compatible clinical syndrome
ETGL - Overview: Ethylene Glycol, Serum
Confirming and monitoring ethylene glycol toxicity
SBL - Overview: Blastomyces Antibody Immunodiffusion, Serum
Detection of antibodies in serum specimens from patients with blastomycosis
CBL - Overview: Blastomyces Antibody Immunodiffusion, Spinal Fluid
Detection of antibodies in spinal fluid specimens from patients with blastomycosis
Detecting lead exposure using hair specimens
HBEL0 - Overview: Hemoglobin Electrophoresis Summary Interpretation
Incorporating and summarizing results into an overall evaluation for the HBEL1 / Hemoglobin Electrophoresis Evaluation, Blood
SP7CS - Overview: Septin-7 Antibody, Cell-Binding Assay, Serum
Detecting septin-7 IgG by cell-binding assay using serum specimens
SOLFM - Overview: Soluble Fibrin Monomer, Plasma
Assisting in the diagnosis of arterial or venous prethrombotic states in various pathological and clinical situations including disseminated intravascular coagulation/intravascular coagulation and fibrinolysis and postoperative monitoring...
APBCS - Overview: Adaptor Protein 3 Beta2 (AP3B2) Antibody, Cell-Binding Assay, Serum
The differential diagnosis of patients presenting with mixed cerebellar and sensory ataxia and myeloneuropathy Evaluating AP3B2 (adaptor protein 3 beta2)-IgG by cell-binding assay using serum specimens
EMAT - Overview: Endomysial Antibodies, IgA, Titer, Serum
Confirmation of a positive IgA-endomysial antibodies result
GPIC - Overview: Glucose Phosphate Isomerase Enzyme Activity, Blood
The evaluation of individuals with Coombs-negative chronic hemolysis
SSF1 - Overview: Nocardia Stain, Varies
Detecting Nocardia species and other partially-acid fast aerobic actinomycetes in clinical specimens
OLIGC - Overview: Oligoclonal Banding, Spinal Fluid
Diagnosis of multiple sclerosis; especially useful in patients with equivocal clinical presentation and radiological findings
NCDCS - Overview: Neurochondrin Antibody, Cell-Binding Assay, Serum
Evaluating neurochondrin-IgG by cell-binding assay using serum from patients presenting with cerebellar and brainstem syndrome
VITE - Overview: Vitamin E, Serum
Monitoring of Vitamin E supplementation/treatment Potentially detecting Vitamin E overdoses
APBTS - Overview: Adaptor Protein 3 Beta2 (AP3B2) Antibody, Tissue Immunofluorescence Titer, Serum
The differential diagnosis of patients presenting with mixed cerebellar and sensory ataxia and myeloneuropathy Reporting an end titer result from serum specimens
NCDTS - Overview: Neurochondrin Antibody, Tissue Immunofluorescence Titer, Serum
Detecting neurochondrin-IgG in serum from patients presenting with cerebellar and brainstem syndrome Reporting an end titer result from serum specimens
PDETS - Overview: Phosphodiesterase 10A (PDE10A) IgG, Tissue Immunofluorescence Titer, Serum
Reporting an end titer result from phosphodiesterase 10A (PDE10A) in serum specimens Evaluation of autoimmune/paraneoplastic neurological syndromes among patients presenting with movement disorders and encephalopathy
PDETC - Overview: Phosphodiesterase 10A (PDE10A) IgG, Tissue Immunofluorescence Titer, Spinal Fluid
Reporting an end titer result from phosphodiesterase 10A (PDE10A) in spinal fluid specimens Evaluation of autoimmune/paraneoplastic neurological syndromes among patients presenting with movement disorders and encephalopathy
SP7TS - Overview: Septin-7 Antibody, Tissue Immunofluorescence Titer, Serum
Detecting septin-7 IgG in serum specimens Reporting an end titer result from serum specimens
MMLYP - Overview: Antimicrobial Susceptibility Panel, Yeast, Varies
Determining in vitro quantitative antifungal susceptibility (minimum inhibitory concentration) of non-fastidious yeast As an aid in the management of certain circumstances, such as: -Refractory oropharyngeal infections due to Candida...
Site Search
Mayo Clinic Ranked No. 1 Hospital Nationwide by U.S. News & World Report - Insights
Report’s 29th annual "Best Hospitals Honor Roll" published online on August 14. Mayo Clinic also ranked No. 1 in more specialties than any other hospital in the country....
NELL-1 [Test in Focus] - Insights
D., discusses how Mayo Clinic Laboratories’ new immunohistochemistry test for the detection of NELL-1 antigen, a biomarker for membranous nephropathy found in 10% to 15% of patients, provides diagnostic...
Looking Back on Clinical Chemistry 1 - Insights
in the Mayo Clinic Medical Laboratory Science program, takes a look back on her Clinical Chemistry 1 course....
Orexin-A/Hypocretin-1 for the Diagnosis of Type 1 Narcolepsy [Test in Focus] - Insights
test to perform as well as to interpret. The orexin-A/hypocretin-1 test is a sensitive and specific alternative to the MSLT to diagnose type 1 narcolepsy....
Week in Review: November 1 - Insights
Top highlights include: Facebook launches into the digital space of healthcare, medical breakthrough for Ebola, and how the brain makes memories.